Cargando…

Lorlatinib for non-small cell lung cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738687/
https://www.ncbi.nlm.nih.gov/pubmed/33363309
http://dx.doi.org/10.18773/austprescr.2020.065
_version_ 1783623172918083584
collection PubMed
description
format Online
Article
Text
id pubmed-7738687
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-77386872020-12-23 Lorlatinib for non-small cell lung cancer Aust Prescr New Drugs NPS MedicineWise 2020-10-22 2020-12 /pmc/articles/PMC7738687/ /pubmed/33363309 http://dx.doi.org/10.18773/austprescr.2020.065 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Lorlatinib for non-small cell lung cancer
title Lorlatinib for non-small cell lung cancer
title_full Lorlatinib for non-small cell lung cancer
title_fullStr Lorlatinib for non-small cell lung cancer
title_full_unstemmed Lorlatinib for non-small cell lung cancer
title_short Lorlatinib for non-small cell lung cancer
title_sort lorlatinib for non-small cell lung cancer
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738687/
https://www.ncbi.nlm.nih.gov/pubmed/33363309
http://dx.doi.org/10.18773/austprescr.2020.065